Klein, I. L. http://orcid.org/0000-0002-4122-6650
van de Loo, K. F. E.
Hoogeboom, T. J.
Janssen, M. C. H.
Smeitink, J. A. M.
van der Veer, E.
Verhaak, C. M.
Custers, J. A. E.
Funding for this research was provided by:
Prinses Beatrix Spierfonds (W.OK17-06)
Article History
Received: 7 September 2020
Accepted: 11 February 2021
First Online: 1 March 2021
Ethics approval and consent to participate
: Ethical approval for this study was granted by the Research Ethics Committee ‘CMO Region Arnhem-Nijmegen’ in the Netherlands on August 28, 2018 (NL63537.091.18, 2018-4509). Participants can only be included in the study after informed consent has been given, as appropriate for the different age-groups within study. For participants below 16 years old, consent for their participation was also obtained from their parents or legal guardians.
: Not applicable.
: This study was not industry sponsored. Dr. Jose Custers, Dr. Thomas Hoogeboom, Dr. Mirian Janssen, Dr. Inge-Lot Klein, Dr. Kim van de Loo, Elja van der Veer and Dr. Christianne Verhaak report no disclosures. Prof. Jan Smeitink is the founding CEO of Khondrion BV.